Improving Gene Therapy Development with Organ-on-a-Chip Technology

Organ-on-a-Chip technology addresses several challenges in gene therapy development, including the poor species translation that impedes current preclinical models. Topics covered in this guide include applications for gene therapy, challenges faced in developing gene therapies, how Organ-on-a-Chip technology can improve many facets of gene therapy development, and more. Download this guide to learn more.

Download Document

    Please fill out the information. If you are already registered, and this information will be filled out for you.

  • Do you currently use Organ-Chips?
    Would you like to speak with an Organ-Chip expert?
  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information, transmitting your contact information to selected trusted partners, and customizing your experience based on the data you enter.



You might also be interested in:

Title image of video

AAV Transduction & Toxicity in the Liver-Chip

The adeno-associated virus (AAV) transduction application for the Emulate Liver-Chip co-culture helps to achieve faster vector optimization results. Learn more about the Liver-Chip co-culture and how it can accelerate the development of gene therapy vectors in a human-relevant liver model.

 

An Introduction to Gene Therapy and Its Applications for Drug Development

What is gene therapy? This guide dives into that question and explores the definition, process, examples, applications, advantages and disadvantages of gene therapy in drug development.

  • <<
  • >>